Engineering the future of sustainable protein, advanced biomaterials, and high-value biochemicals through next-generation strain development, continuous bioprocessing, and AI-optimized scale-up.
From molecular design to commercial-grade output, our fermentation portfolio integrates synthetic biology, process engineering, and rigorous quality systems.
Recombinant protein expression, enzyme production, and dairy-free casein/whey alternatives at industrial scale.
High-yield filamentous fungi cultivation for texture-optimized plant-based proteins and novel food matrices.
PHA, PHA blends, and fermentation-derived bioplastics engineered for compostability and mechanical resilience.
CGMP-compliant fermentation for active pharmaceutical ingredients, vitamins, amino acids, and fine chemicals.
Real-time metabolic modeling, automated fed-batch optimization, and digital twin simulation for yield maximization.
Perfusion systems, continuous downstream separation, and integrated purification trains reducing OPEX by up to 38%.
Our proprietary pipeline accelerates time-to-market while maintaining pharmaceutical-grade consistency across all product categories.
CRISPR-mediated metabolic engineering, directed evolution, and high-throughput screening of 10,000+ candidates annually.
2L–20L bioreactor validation, media optimization, and kinetic modeling to establish baseline yields.
200L–2,000L continuous operation, downstream integration testing, and regulatory documentation preparation.
5,000L–50,000L production trains with automated CIP/SIP, real-time QC, and batch traceability systems.
Regional fermentation campuses optimized for substrate sourcing, regulatory compliance, and logistics efficiency.
Explore joint development agreements, licensing opportunities, or commercial supply partnerships for next-generation bio-manufactured ingredients and materials.